DVN

Tổng Công ty Dược Việt Nam - CTCP ·UPCOM ·2026Q1

▲▲ Improving positively

Operating efficiency is improving Net margin 13.03%, +4.44pp YoY
Price
21,100
Latest close
03 Jun 2026
P/E 7.30x
P/B 1.20x
EPS 2,891
BVPS 17,644
ROE 17.7%
ROA 9.6%
Profit Margin 12.1%
Asset Turnover 0.79x
Equity Mult. 1.85x

TTM · Applied to: EPS, ROE, ROA, Net Margin, Asset Turnover, Debt/Equity

What Is Changing

On a TTM 2026Q1 basis, DVN has not accelerated revenue sharply, but profitability is improving visibly — profit is at an all-time high. However, operating cash flow is significantly negative relative to profit — this needs monitoring in coming periods.

TTM REVENUE
VND 5,654bn
+1.4%YoY
NET MARGIN
13.03%
+4.4ppYoY
TTM NET PROFIT
VND 737bn
+53.8%YoY
CFO / Net Income
-0.35x
negative cash flow vs profit
Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24 Q4'23 Q3'23 Q2'23
Revenue 1,237.4 1,691.3 1,326.9 1,398.8 1,242.9 1,578.1 1,219.7 1,533.8 1,194.8 1,765.5 1,270.8 1,320.6
Growth -27% +27% -5% +13% -21% +29% -20% +28% -32% +39% -4%
Net Income 153.7 340.2 92.3 150.5 85.8 54.6 79.1 259.4 94.4 82.9 58.7 168.8
Net Margin 12.42% 20.12% 6.95% 10.76% 6.91% 3.46% 6.49% 16.91% 7.90% 4.70% 4.62% 12.79%

Drivers of DVN's profit

TTM

Net profit attributable to parent increased vs last year, mainly helped by higher associates income. Supporting and offsetting drivers:

Associates income ↑ 300.2bn
Gross profit ↓ 54.1bn
TTM

Net profit attributable to parent increased vs prior quarter, mainly helped by higher associates income. Supporting and offsetting drivers:

Associates income ↑ 58.4bn
Finance costs ↓ 20.7bn
Financial income ↓ 12.2bn

Financial Highlights

Detailed analysis of each financial dimension

ROE = Profit Margin × Asset Turnover × Equity Multiplier

2025Q1 14.0% = 8.6% × 0.88 × 1.85
2026Q1 19.0% = 13.0% × 0.79 × 1.85

ROE rose from 14.0% to 19.0% — mainly driven by net margin, despite asset turnover moving in the opposite direction.

Net margin: 13.0% +4.4pp Asset turnover: 0.79x -0.10x Leverage: 1.85x -0.00x

Is the profit sustainable?

Accounting profit is positive but operating cash flow has not caught up — needs more time to confirm.

very positive positive stable watch under pressure

What is driving the margin?

Net margin expanded to 13.03%, rising 4.4pp. Core operating signals are improving as SG&A / Revenue fell 0.1pp are enough to offset pressure from Gross margin fell 1.1pp (in addition, Other profit / Revenue rose 0.2pp added support while Net financial result / Revenue fell 0.2pp remained a drag).

The improvement comes from core operations — this is a high-quality margin expansion.

Profitability trend

Net Margin 13.03% +4.4pp
Gross Margin 9.65% −1.1pp
SG&A / Revenue 7.39% −0.1pp

TTM YoY · 2025Q1 -> 2026Q1

Is capital being used efficiently?

Return on capital rose, but cash cycle lengthened by 23.7 days — working capital needs watching.

Is capital being deployed efficiently?

ROIC expanded to 13.26%, rising 3.3pp. That translates to 13.26 in after-tax operating profit for every 100 units of operating capital. The main driver is NOPAT margin rose 4.2pp, with capital turnover fell 0.15x; while invested capital rose by 721bn.

Capital efficiency improved through NOPAT margin — this is a quality-led improvement when operating profit leads.

CAPITAL EFFICIENCY TREND

TTM YoY · 2025Q1 -> 2026Q1

ROIC 13.26% +3.3pp
NOPAT Margin 12.39% +4.2pp
Capital Turnover 1.07x −0.15x
Average Invested Capital 5,282.4bn +720.9bn

Balance Sheet

ROIC is improving — the asset structure below shows how capital is being allocated. Capital structure is conservative with low leverage — liabilities at 0.92x equity, net debt at 0.38x equity.

Inventory ended the period at 1,975.1bn, roughly 26.3% of total assets.

Over the last 12 months, working capital absorbed 338.5bn of cash, mainly because of higher receivables and higher inventories. Part of that drag was offset by higher payables.

Working Capital Drivers

TTM YoY · 2025Q1 -> 2026Q1

Receivables increased → lower CFO: −345.2bn
Inventories increased → lower CFO: −269.8bn
Payables increased → higher CFO: +276.6bn

Working Capital Efficiency

Cash conversion cycle lengthened by 23.7 days versus the same period last year. The main moves came from DIO rose 18.8 days, DSO rose 12.1 days, and DPO rose 7.2 days.

Working capital cycle lengthened mainly due to slower inventory turnover — more capital is being tied up in inventory.

Watchpoints

Cash conversion cycle remains stretched

CCC stands at 125.6 days, suggesting that working capital remains tied up for a relatively long operating cycle.

Receivables collection is slowing

DSO increased by +12.1 days, pointing to slower receivables turnover.

Working Capital Efficiency

TTM YoY · 2025Q1 -> 2026Q1

Receivables 117.7 days +12.1 days
Inventory 129.2 days +18.8 days
Payables 121.3 days +7.2 days
Cash Conversion Cycle 125.6 days +23.7 days

Is financial risk significant?

Leverage is safe but FCF is negative at 249.5bn due to capex of 10.4bn — an investment choice, not an urgent risk.

Leverage & Liquidity

Leverage looks fairly comfortable, with net debt / equity at 0.38x and interest coverage at 7.65x.

At present, short-term debt accounts for 98.2% of total debt, cash equals 2.7% of debt, and total debt stands at 1,616.8bn.

Watchpoints

Short-term refinancing pressure is meaningful

Short-term debt accounts for 98.2% of total debt, raising near-term refinancing needs.

Cash buffer is thin relative to debt

Cash / debt stands at 2.7%, leaving limited liquidity buffer to monitor.

Leverage and liquidity trend

Net Debt / Equity 0.38x +0.04x
Interest Coverage 7.65x +2.48x
Cash / Debt 2.7% −1.4pp
Short-term Debt / Total Debt 98.2% +0.5pp
CFO / NI -0.35x +0.08x

TTM YoY · 2025Q1 -> 2026Q1

Cash Flow

Operating cash flow reached -160.2bn in 2025, against investing cash flow of -111.3bn.

Post-investment cash flow was negative +271.6bn. Financing cash flow was positive +28.2bn.

CFO / net income was -0.35x.

After spending +10.4bn on fixed-asset investment, the business generated trailing free cash flow of −249.5bn.

Cash Conversion

TTM Cash Conversion · 2025Q1 -> 2026Q1

CFO TTM 239.0bn −56.0bn
Cash Capex 10.4bn +1.6bn
FCF TTM −249.5bn −57.6bn

Investment Takeaway

The business is heading the right way, but the current picture is still at partial confirmation — not yet a fully clean case. The positive points have clearly improved, showing the operating base is better than before. The brighter spot is operating efficiency, with net margin improving 4.4 pp. The next item to monitor is the earnings mix, when non-core contribution is 20.5%. The main risk still sits in leverage and liquidity, with interest coverage at 7.65x.

Improvement: operating efficiency is getting better, with trailing-12M net margin at 13.03% after expanding 4.4pp versus the same period last year.

Watchpoint: the earnings mix still needs monitoring, with net financial result still accounting for 20.5% of PBT and CFO / net income currently at -0.35x.

Key risk: leverage and liquidity remain a pressure point, with net debt / equity at 0.38x and a thin cash buffer.

Statement Data

Item 2025 2024 2023 2022 2021
Net Revenue
5,661.9 5,521.8 5,583.2 5,540.6 4,438.5
Cost of Goods Sold
5,108.1 4,929.1 4,985.4 4,996.6 0.0
Gross Profit
553.8 592.7 597.8 544.0 433.9
Financial Expenses
120.4 103.7 151.7 202.4 -19.4
Selling Expenses
281.4 274.0 263.5 286.6 -241.1
General and Administrative Expenses
131.6 149.0 143.4 135.7 -112.1
Operating Profit
669.4 483.1 427.3 131.8 243.0
Profit Before Tax
705.7 509.2 425.0 131.9 244.1
Net Income
670.9 468.1 390.3 110.4 228.9
Profit Attributable to Parent
618.9 420.8 346.0 84.1 208.0
Earnings per Share
2,566.00 1,729.00 1,391.00 322.00 877.00

Explore Other Stocks In The Same Sector

DHG, IMP, DBD, DTP, TRA, DMC, DP3, OPC, NDC, DAN, PMC, VDP, DHT, FIT, DHD, AGP, DVM, CNC, PBC, LDP, DPH, VMD, NDP, HDP, DCL, PPP, VET, MTP, MKV, DHN, MED, DBT, DTG, DPP, BIO, VNY, DBM, MKP, TW3, DTH, NTF, BCP, UPH, SPM, DP2, VXP

Need support? If you need support with content lookup or want to provide feedback about content on the website, please contact us below.